	The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study. Int J Clin Oncol Huang T, Fan Z, Wang Y, Yan X, Yang H, Wang S, Pang D, Li H, Wang H, Geng C, Huang L, Sun Y, Wang B, Sun G, Siddiqui A, Restuccia E, Shao Z. PMID: 42098463 [PubMed - as supplied by publisher]
	The impact of online-delivered controlled physical activity on cardiorespiratory fitness and heart rate variability in breast cancer survivors. Sci Rep Bohovicová L, , Bure, Palácová M, Petráková K, Gescheidtová L, , Kiss I, Bazalová P, Hrn, , Halámková J. PMID: 42098205 [PubMed - as supplied by publisher]
	A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study. Ann Oncol Garrigós L, Ruiz-Borrego M, Pérez-García JM, Guerrero-Zotano A, Cortés-Salgado A, Kuemmel S, Colleoni M, Reboredo-Rendo C, Bermejo B, Blancas I, Gavila J, Fabi A, Morales C, Stradella A, Carañana V, Martínez-de Dueñas E, Albacar C, Ballesteros-Cidras O, Martrat G, Iacobucci S, Boix O, Berenguer-Molins P, Alcalá-López D, Cortés J, Llombart-Cussac A, PHERGain-2 investigators. PMID: 42097893 [PubMed - as supplied by publisher]
	HIV care continuity for women in postconflict Tigray: assessing mother-to-child transmission rates, infant health and cervical cancer screening. BMJ Glob Health Kebede HK, Gesesew HA, Mwanri L, Ward P. PMID: 42097707 [PubMed - indexed for MEDLINE]
	What is the adherence to an exercise intervention during (neo-)adjuvant chemotherapy among Swedish patients with breast cancer? Data from the Phys-Can randomised controlled trial. BMJ Open Henriksson A, Stenling A, Mazzoni AS, Sjövall K, Börjeson S, Berntsen S, Bean CG, Buffart LM, Nordin K, Demmelmaier I. PMID: 42097659 [PubMed - indexed for MEDLINE]
	Examining the Influence of Social Network Factors on Weight Loss Among Latina and Non-Hispanic White Breast Cancer Survivors: Observational Cohort Study. JMIR Form Res Janio E, Hoyt MA, Biegler KA, Al-Majid S, Chen Y, Kobsa A, Sorkin DH. PMID: 42097613 [PubMed - indexed for MEDLINE]
	RE: Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a prospective cohort study. J Natl Cancer Inst Chen Y, Tian G. PMID: 42097288 [PubMed - as supplied by publisher]
	In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells. Eur J Med Chem Lu Y, Chen K, Wang H, Zhang C, Huang X, Wang Z, Chen H, Niu M, Yao H, Zheng L, Xu S, Guo Q. PMID: 42097058 [PubMed - as supplied by publisher]
	NOS2 and COX2 impact the spatial landscape of CD8(+) T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival. Redox Biol Ridnour LA, Cheng RY, Heinz WF, Coutinho LL, Palmieri EM, Rangel MC, Anderson SK, McVicar DW, Hewitt SM, Wong ST, Li X, Ambs S, Billiar TR, Glynn SA, Chang JC, Lockett SJ, Wink DA. PMID: 42097035 [PubMed - as supplied by publisher]
	Precision nutrition in breast cancer: Towards patient- and tumour-informed dietary strategies. Clin Nutr Crespo-García C, Taaffe DR, Peddle-McIntyre CJ, Jeffery E, Campbell JP, Thomas R, Galvao DA, Newton RU. PMID: 42096978 [PubMed - as supplied by publisher]
	Experiences and challenges in implant based breast reconstruction decision making among young breast cancer patients: A qualitative study. Acta Psychol (Amst) Gao Y, Liu S, Shen Y, Shen M, Liu J, Ning L, Cai L. PMID: 42096952 [PubMed - as supplied by publisher]
	New pyrimidine compounds as potent anti-breast cancer agents: synthesis, biological evaluation and computational studies. Bioorg Chem Sutar NR, Alegaon SG, Gharge S, Ranade SD, Kamble PA. PMID: 42096928 [PubMed - as supplied by publisher]
	Diagnostic value of diffusion-weighted MRI as an imaging biomarker for ovarian cancer: A systematic review and meta-analysis. Surg Oncol Pugliesi RA, Mansour KB, Apitzsch J, Maalouf N, Krysiak R, Andrisani A, Billone V, Ferrero S, Gullo G. PMID: 42096765 [PubMed - as supplied by publisher]
	Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer. Am Soc Clin Oncol Educ Book Wong SM, Speers C, Schaverien MV. PMID: 42096667 [PubMed - indexed for MEDLINE]
	Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy. Obstet Gynecol Surv Kouri A, Lara O, Stein J. PMID: 42096621 [PubMed - indexed for MEDLINE]
	Autoencoder/RandomForest-TabPFN for Cross-Cancer Metabolomics: Prostate and Breast Cancer Diagnosis Using Paper Spray and Ion Mobility-Mass Spectrometry Techniques. Gigascience Hauns S, Pinto FG, Khyriem C, Singh A, Al-Sadi A, Yazeedi TA, Mohammad R, Cisse B, Garrett TJ, Uddin M, Soares NC, Backofen R, Alkhnbashi OS. PMID: 42096511 [PubMed - as supplied by publisher]
	Correction: Evaluation of Large Language Models for Radiologists' Support in Multidisciplinary Breast Cancer Teams: Comparative Study. JMIR Med Inform Jiang H, Yang C, Zhou W, Yin CL, Zhou S, He R, Ran G, Wang W, Wu M, Yu J. PMID: 42096260 [PubMed - in process]
	[Early preeclampsia associated with hydatidiform mole and pulmonary metastasis: A case report]. Rev Med Inst Mex Seguro Soc Rivera-Hernández DA, Montes-Sevilla LD, Murcia-Acero DX, Castillo Medina AL. PMID: 42096254 [PubMed - indexed for MEDLINE]
	Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer. Discov Oncol Yan T, Yu B, Qian F, Fang L, Zhao Y, Ye D. PMID: 42096008 [PubMed - as supplied by publisher]
	Deep learning model for noninvasive prediction of Ki-67 expression and prognostic stratification in breast cancer: a multicenter retrospective study. Eur Radiol Yu W, Chen P, Chai S, Ding W, Zhang L. PMID: 42095876 [PubMed - as supplied by publisher]

Articles 1 - 20 / 328331

Page 1 of 16417



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy